First Trust Advisors’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,039
Closed -$636K 2577
2024
Q3
$636K Sell
12,039
-9,350
-44% -$494K ﹤0.01% 2115
2024
Q2
$1.16M Sell
21,389
-16,560
-44% -$897K ﹤0.01% 1911
2024
Q1
$2.66M Buy
+37,949
New +$2.66M ﹤0.01% 1610
2023
Q2
Sell
-58,292
Closed -$2.05M 2369
2023
Q1
$2.05M Sell
58,292
-50,019
-46% -$1.76M ﹤0.01% 1682
2022
Q4
$4.96M Buy
108,311
+41,947
+63% +$1.92M 0.01% 1199
2022
Q3
$3.22M Buy
66,364
+31,485
+90% +$1.53M ﹤0.01% 1417
2022
Q2
$1.37M Sell
34,879
-32,123
-48% -$1.26M ﹤0.01% 1864
2022
Q1
$2.47M Sell
67,002
-87,077
-57% -$3.2M ﹤0.01% 1698
2021
Q4
$7.02M Buy
+154,079
New +$7.02M 0.01% 1207
2021
Q3
Sell
-75,858
Closed -$1.5M 2539
2021
Q2
$1.5M Buy
75,858
+26,570
+54% +$526K ﹤0.01% 1917
2021
Q1
$1.15M Buy
49,288
+10,583
+27% +$246K ﹤0.01% 1944
2020
Q4
$804K Buy
+38,705
New +$804K ﹤0.01% 1981